Loading
Latest filing published 05 Dec 2025 for Medexus Pharmaceuticals Inc., €13k.
No signal scores available.
Only one filing by Richard Labelle is known so far (5 December 2025): an option exercise, €13k, in Medexus Pharmaceuticals Inc. That is too little to draw conclusions. This summary is built from SEDI disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
1 of 1 declaration